Milan Dodig, MD
NPI 1730123514 · Gastroenterology Physician · Cleveland, OH
Enrolled with Medicare as Practitioner - Gastroenterology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1730123514
- Entity type
- Individual
- Primary specialty
- Gastroenterology PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Male
- License
- 35076733D (OH)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
582 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 136 | $85 |
| Biopsy of Esophagus, Stomach, And/Or Upper Small Bowel Using a Flexible Endoscope43239 | 126 | $111 |
| Biopsy of Large Bowel Using a Flexible Endoscope45380 | 56 | $173 |
| Removal of Polyps Or Growths of Large Bowel Using an Endoscope With Mechanical Snare45385 | 42 | $239 |
| Dilation of Esophagus43450 | 36 | $36 |
| Colorectal Cancer Screening; Colonoscopy on Individual at High Risk |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 50 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Pantoprazole Sodium | 1,303 | 395 |
| Famotidine | 597 | 155 |
| Omeprazole | 364 | 120 |
| Linaclotidebrand: Linzess | 321 | 89 |
| Sucralfate | 185 | 48 |
| Colestipol Hcl | 183 | 65 |
| Dicyclomine Hcl | 166 | 60 |
| Ondansetron Hcl |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$4,275 across 250 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-06-15
- Last updated
- 2007-07-08
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.